Actual results could differ materially from those currently anticipated due to a number of factors and risks, as discussed in the Company’s Annual Report on Form 20-F for the year ended April 30 ...

NEW YORK, Sept. 24, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous ...

Lexaria previously announced, on September 3, 2024, that it had entered into a Material Transfer Agreement ("MTA") with a pharmaceutical company ("PharmaCO") to evaluate Lexaria's DehydraTECH TM ...

3 June 2025 ValiRx PLC ("ValiRx" or the "Company") New Evaluation and Material Transfer Agreement. ValiRx plc (the "Company") (AIM: VAL), a life sciences company focusing on early-stage cancer ...

A Material Transfer Agreement (MTA) governs the transfer of biological, chemical, archeological and other materials from one organization to another. Usually the materials in question are proprietary ...

Under the agreement, the company's oncolytic virus candidates ELC-100 and ELC-201 will be included in tests aimed at developing a new type of companion diagnostic to predict the potential success ...

(2024-10-02 | NDAQ:IPA) ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus. Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of ...

Lexaria previously announced, on September 3, 2024, that it had entered into a Material Transfer Agreement ("MTA") with a pharmaceutical company ("PharmaCO") to evaluate Lexaria's DehydraTECH TM ...

Under this agreement, Biotheus will receive a specialized antibody asset from Talem Therapeutics, a subsidiary of ImmunoPrecise Antibodies. Biotheus plans to use this asset in conjunction with its ...

Seelos Therapeutics announces the signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development Activity (USAMMDA) to evaluate SLS-002 for treatment of PTSD. PR Newswire .

Kelowna, British Columbia –TheNewswire -May 12, 2025 -Lexaria Bioscience Corp. (LEXX) (Nasdaq: LEXX, LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides ...